Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2003
05/13/2003US6562847 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562839 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
05/13/2003US6562837 Use of tetrahydroisoquinoline compounds for the treatment of septicemia
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562824 Dihydropyridine soft drugs, and related compositions and methods
05/13/2003US6562823 Inhibition of farnesyl-protein transferase has been shown to block the growth of Ras-transformed cells in soft agar
05/13/2003US6562822 Heterocyle carboxamides as antiviral agents
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003US6562816 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562806 Pyrrolobenzodiazepines
05/13/2003US6562794 Cosmetic and dermatological formulations comprising flavonoids
05/13/2003US6562788 Novel class of peptide inhibitors of topoisomerase II chemotherapeutic antitumor agents
05/13/2003US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties
05/13/2003US6562619 Genration of preferential cell pools; prepare nutrient broth containing growth factor, inoculate with cells, propagate cells, recover cells
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562362 Copolymer of n-isopropylacrylamide and an ionic strength or pH sensitive monomer; nondegradable; side effects reduction
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
05/13/2003US6562319 4-(phenylamino)quinazolines
05/13/2003CA2428649A1 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003CA2261724C Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/13/2003CA2045885C Inhibition of mammalian muscle wasting and protein degradation by tetracyclines
05/09/2003CA2464707A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/08/2003WO2003038430A1 Screening method
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003038110A2 7118, a human arginine n-methyltransferase family member and uses therefor
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037909A1 Acyclic linker-containing oligonucleotides and uses thereof
05/08/2003WO2003037902A1 Separation of regioisomers of metal phthalocyanines
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037898A1 Pyrimido [4,5-b] indole derivatives
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037877A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS
05/08/2003WO2003037876A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037864A1 Indole compound and medicinal use thereof
05/08/2003WO2003037860A2 Purine analogs having hsp90-inhibiting activity
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037432A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037379A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003WO2003037377A1 Preventives/remedies for proliferative organ diseases, chronic arthritic diseases, hypertrophic scar or keloid
05/08/2003WO2003037375A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003WO2003037364A1 Interleukin-18 inducing agent
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037350A1 New dry and aqueous epinastine-syrup-formulation
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037347A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
05/08/2003WO2003037344A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
05/08/2003WO2003037342A1 Method of treating depression with delta receptor agonist compounds
05/08/2003WO2003037341A1 Method for the treatment of overactive bladder
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037333A1 Pyridine derivatives as nmda-receptor subtype blockers
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037329A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003WO2003037322A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
05/08/2003WO2003037321A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
05/08/2003WO2003037318A1 Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
05/08/2003WO2003037316A1 Peroxisome proliferator activated receptor ligands and process for producing the same
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003WO2003037306A2 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract
05/08/2003WO2003037299A1 Novel formulation
05/08/2003WO2003037296A2 Methods and dosage forms for improving the bioavailability of therapeutic agents
05/08/2003WO2003037269A2 Di-, tri,- and tetra-peptides having antiangiogenic activity
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037168A2 Methods and formulations for minimizing spasticity in blood vessel grafts
05/08/2003WO2003037166A2 Devices and methods for the restoration of a spinal disc
05/08/2003WO2003037165A2 System and method for the pretreatment of the endplates of an intervertebral disc
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003005955A3 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2003000027A3 Blocking peptide for inflammatory cell secretion
1 ... 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 ... 1564